Use of aspirin for the primary prevention of cardiovascular disease is a controversial topic. Recent evidence, compounded by the ACC/AHA guidelines on primary prevention suggests that Aspirin risks of gastrointestinal bleeding outweigh the benefit of cardiovascular protection.

This presentation will cover second-line therapy options available for the treatment of type 2 diabetes. Attention will be given to the benefits and risks of those treatment options in the older adult population. Patient cases will be utilized to reinforce appropriateness in older adults.

Urine drug testing is a valuable tool for providers who are caring for patients on opioid medications as well as other controlled substances. It is important for them to know differences among types of tests and how to interpret results based on patient-specific factors.

The presentation will provide detailed information on how to access treatment for substance use in the state of Alabama, specifically those with OUD. Many providers and practitioners in our state are unaware of the resources offered through state systems or for profit agencies.